公司概覽
業務類別 Biotechnology
業務概覽 EXoZymes Inc is focused on using a biomanufacturing platform to create valuable biochemicals, including Active Pharmaceutical Ingredients or APIs, biofuels, food flavors, and cosmetics, offering a sustainable alternative to traditional chemical production methods. The company believes its platform will enable scalable production of chemical molecules found in nature in a process that is alternative to and more environmentally friendly and sustainable than the typical methodsused today, such as chemical synthesis, natural extraction, and synthetic biology.
公司地址 750 Royal Oaks Drive, Suite 106, Monrovia, CA, USA, 91016
電話號碼 +1 626 415-1488
傳真號碼 --
公司網頁 https://www.exozymes.com
員工數量 32
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Mr. Michael Heltzen President and Chief Executive Officer 美元 358.33K 30/03/2026
Mr. Fouad Nawaz Vice President, Finance and Principal Accounting Officer 美元 214.58K 30/03/2026
Dr. Tyler Korman Chief Scientific Officer 美元 222.92K 30/03/2026
Dr. Paul Opgenorth Vice President, Development 美元 219.79K 30/03/2026
Mr. Damien Perriman Chief Commercial Officer 美元 237.80K 30/03/2026
 
董事會成員
董事會 職務 更新日期
Mr. Anthony DiGiandomenico Director 28/09/2026
Mr. Christopher A. Marlett Chairman of the Board 28/09/2026
Dr. Lon Edward Bell, PhD Independent Director 28/09/2026
Mr. James J. Lalonde Independent Director 28/09/2026
Dr. James U. Bowie, PhD Independent Director 28/09/2026
Mr. Edgardo Rayo Independent Director 28/09/2026
 
所屬ETF (更新日期: 07/11/2026 04:50)
代號 名稱 佔比% ▼ 持有日期
IWCiShares Micro-Cap ETF0.11%30/10/2026
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.